Abstract:Key PointsBiofilms of Vibrio cholerae, the causative agent of cholera, have an important role during the aquatic and intestinal phases of the bacterial life cycle, conferring greater resistance to environmental stresses and increasing infectivity.V. cholerae biofilm formation is a multistep process that begins with initial attachment via the bacterial mannose-sensitive haemagglutinin (MSHA) pili. The key components of a V. cholerae biofilm are secreted by the cell at various times during biofilm formation and include Vibrio polysaccharide (VPS), the biofilm proteins rugosity and biofilm structure modulator A (RbmA), Bap1 and RbmC, and extracellular DNA, all of which are critical for the formation of mature biofilms.Biofilm formation in V. cholerae is controlled by an integrated network of transcriptional regulators. The major transcriptional activators include VpsR, VpsT and AphA, and major transcriptional repressors include HapR and H-NS; alternative RNA polymerase sigma factors, regulatory small RNAs and signalling molecules also function as regulators of this complex process.Nucleotide-based signals play an important part in controlling biofilm formation and include cyclic di-GMP (c-di-GMP), which positively regulates biofilm formation and negatively regulates motility to influence the planktonic-to-biofilm transition. Additionally, cyclic AMP represses biofilm formation, and guanosine tetraphosphate and guanosine pentaphosphate (collectively called (p)ppGpp) enhance biofilm formation.V. cholerae biofilm formation is influenced by a number of fluctuating environmental factors, including nutritional status, shifts in salinity and osmolarity, phosphate limitation, the presence of polyamines, variations in calcium levels, and exposure to indole and bile. The ability of V. cholerae to activate or repress biofilm formation in response to external signals probably contributes to the environmental survival and persistence of the bacterium and demonstrates the complexity of the biofilm regulation programme.New small-molecule therapeutics have emerged that target and disrupt V. cholerae biofilm formation. Such therapeutics include quorum sensing inhibitors, disruptors of c-di-GMP signalling and compounds with unknown molecular targets. Whole-cell phenotypic imaging coupled with cellular-viability measurements have been used to differentiate bactericidal agents and compounds that selectively disrupt biofilm formation without affecting cell survival. These studies have led to the discovery of several compounds that show promise for biofilm inhibition and for the treatment of cholera.

Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes

Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with aromatic sulphonamides and clinically licenced drugs – a joint docking/molecular dynamics study

Redox Pathway Sensing Bile Salts Activates Virulence Gene Expression in Vibrio Cholerae

Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor

Detection of Potential Phytochemicals against ctxAB Toxin to Combat Cholera

Antibiotic resistance mechanisms of Vibrio cholerae

A comprehensive review of therapeutic approaches available for the treatment of cholera

Mechanism of Antibiotic Resistance and Pathogenicity of Vibrio cholerae

In-Silico Designing a Multi-Peptide Vaccine: Against Vibrio Cholera

Wastewater-based surveillance of Vibrio cholerae: Molecular insights on biofilm regulatory diguanylate cyclases, virulence factors and antibiotic resistance patterns

A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models

Whole Genome Sequencing and Pan-Genomic Analysis of Multidrug-Resistant Vibrio cholerae VC01 Isolated from a Clinical Sample

Identification of Small Molecule Inhibitors of the Pathogen Box against Vibrio cholerae

Comprehensive in silico analyses of fifty-one uncharacterized proteins from Vibrio cholerae

Preparation and evaluation of chitosan nanoparticles containing CtxB antigen against Vibrio cholera

Identifying therapeutic antibacterial peptides against Vibrio cholerae to inhibit the function of Na(+)-translocating NADH-quinone reductase

Postgenomic approaches to cholera vaccine development

Adaptation to bile and anaerobicity limits Vibrio cholerae phage adsorption

Carbohydrate inhibitors of cholera toxin

Living in the matrix: assembly and control of Vibrio cholerae biofilms

Involvement of cell envelope components in the pathogenesis of Vibrio cholerae: targets for cholera vaccine development